Redhill Biopharma
RDHL
29 hedge funds and large institutions have $21.5M invested in Redhill Biopharma in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
19% more capital invested
Capital invested by funds: $18M → $21.5M (+$3.46M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
6% less funds holding
Funds holding: 31 → 29 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$3.83M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$432K |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$109K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$69.1K |
| 5 |
CBU
CIBC Bank USA
Chicago,
Illinois
|
+$57.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$312K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$180K |
| 3 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
-$155K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$110K |
| 5 |
OC
Oppenheimer & Co
New York
|
-$66K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $9K | +$5.76K | +1 | +100% |
|
27
Bank of America
Charlotte,
North Carolina
| $5K | -$11.5K | -2 | -67% |
|
|
PVH
28
Psagot Value Holdings
Tel Aviv,
Israel
| $4K | – | – | – |
|
29
Wells Fargo
San Francisco,
California
| $3K | – | – | – |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
VF
31
Virtu Financial
New York
| – | -$312K | -61 | Closed |
|
|
DCM
32
DAFNA Capital Management
Los Angeles,
California
| – | -$180K | -35 | Closed |
|
|
SM
33
Sabby Management
Miami Beach,
Florida
| – | -$110K | -21 | Closed |
|
|
OC
34
Oppenheimer & Co
New York
| – | -$66K | -13 | Closed |
|
35
JP Morgan Chase
New York
| – | -$4K | -1 | Closed |
|
|
TWA
36
TCI Wealth Advisors
Tucson,
Arizona
| – | -$1K | – | – |
|
RDHL Hedge Fund Activity: Q1 2018 in Review
29 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q1 2018, worth a combined $21.5M — up 19% from $18M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RDHL and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 10 added.
The largest buyer was 683 Capital Management, adding an estimated $3.83M. The largest seller was Virtu Financial, exiting entirely with an estimated $312K sold.
- 29 institutional investors held Redhill Biopharma (RDHL) as of Q1 2018, down from 31 in Q4 2017.
- Funds reported $21.5M of Redhill Biopharma stock for Q1 2018, up 19% quarter-over-quarter.
- 3 funds opened new Redhill Biopharma positions in Q1 2018 and 5 closed out, a net change of -2 holders.
- The largest Redhill Biopharma buyer in Q1 2018 was 683 Capital Management, an estimated $3.83M added.
- The largest Redhill Biopharma seller in Q1 2018 was Virtu Financial, an estimated $312K sold.
Based on aggregated 13F filings for Q1 2018.